Search research articles
Contact Us
Filters
Showing results (471-480 of 522) with videos related to
Page
of 53
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
January 12, 2023
Circulating galectin-1 delineates response to bevacizumab in melanoma patients and reprograms endothelial cell biology
Nadia Bannoud, Juan C Stupirski, Alejandro J Cagnoni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2023
Correction: sFRP2 Supersedes VEGF as an Age-related Driver of Angiogenesis in Melanoma, Affecting Response to Anti-VEGF Therapy in Older Patients
Mitchell E Fane, Brett L Ecker, Amanpreet Kaur, et al.
Journal for Immunotherapy of Cancer
|
April 25, 2024
Severe acute myositis and myocarditis on initiation of 6-weekly pembrolizumab post-COVID-19 mRNA vaccination
Robert A Watson, Weiyu Ye, Chelsea A Taylor, et al.
Animals : an Open Access Journal From MDPI
|
December 11, 2022
Diagnosing Intramammary Infection: Meta-Analysis and Mapping Review on Frequency and Udder Health Relevance of Microorganism Species Isolated from Bovine Milk Samples
Daryna Kurban, Jean-Philippe Roy, Fidèle Kabera, et al.
Cancer Cell
|
April 30, 2013
Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP
Min Lu, Hilde Breyssens, Victoria Salter, et al.
Cancer Cell
|
November 16, 2016
Restoring p53 Function in Human Melanoma Cells by Inhibiting MDM2 and Cyclin B1/CDK1-Phosphorylated Nuclear iASPP
Min Lu, Hilde Breyssens, Victoria Salter, et al.
Journal of Dairy Science
|
April 20, 2023
Invited review: Selective treatment of clinical mastitis in dairy cattle
Ellen de Jong, Kayley D McCubbin, David Speksnijder, et al.
The Lancet. Oncology
|
April 22, 2014
Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study
Pippa G Corrie, Andrea Marshall, Janet A Dunn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 21, 2014
Phase I expansion and pharmacodynamic study of the oral MEK inhibitor RO4987655 (CH4987655) in selected patients with advanced cancer with RAS-RAF mutations
Lisa Zimmer, Fabrice Barlesi, Maria Martinez-Garcia, et al.
Cell Reports. Medicine
|
February 28, 2024
Nilotinib in KIT-driven advanced melanoma: Results from the phase II single-arm NICAM trial
James Larkin, Richard Marais, Nuria Porta, et al.
Page
of 53
Search research articles
Search
Showing results (471-480 of 522) with videos related to
Sort By:
Page
of 53
Proceedings of the National Academy of Sciences of the United States of America
|
January 12, 2023
Circulating galectin-1 delineates response to bevacizumab in melanoma patients and reprograms endothelial cell biology
Nadia Bannoud, Juan C Stupirski, Alejandro J Cagnoni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2023
Correction: sFRP2 Supersedes VEGF as an Age-related Driver of Angiogenesis in Melanoma, Affecting Response to Anti-VEGF Therapy in Older Patients
Mitchell E Fane, Brett L Ecker, Amanpreet Kaur, et al.
Journal for Immunotherapy of Cancer
|
April 25, 2024
Severe acute myositis and myocarditis on initiation of 6-weekly pembrolizumab post-COVID-19 mRNA vaccination
Robert A Watson, Weiyu Ye, Chelsea A Taylor, et al.
Animals : an Open Access Journal From MDPI
|
December 11, 2022
Diagnosing Intramammary Infection: Meta-Analysis and Mapping Review on Frequency and Udder Health Relevance of Microorganism Species Isolated from Bovine Milk Samples
Daryna Kurban, Jean-Philippe Roy, Fidèle Kabera, et al.
Cancer Cell
|
April 30, 2013
Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP
Min Lu, Hilde Breyssens, Victoria Salter, et al.
Cancer Cell
|
November 16, 2016
Restoring p53 Function in Human Melanoma Cells by Inhibiting MDM2 and Cyclin B1/CDK1-Phosphorylated Nuclear iASPP
Min Lu, Hilde Breyssens, Victoria Salter, et al.
Journal of Dairy Science
|
April 20, 2023
Invited review: Selective treatment of clinical mastitis in dairy cattle
Ellen de Jong, Kayley D McCubbin, David Speksnijder, et al.
The Lancet. Oncology
|
April 22, 2014
Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study
Pippa G Corrie, Andrea Marshall, Janet A Dunn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 21, 2014
Phase I expansion and pharmacodynamic study of the oral MEK inhibitor RO4987655 (CH4987655) in selected patients with advanced cancer with RAS-RAF mutations
Lisa Zimmer, Fabrice Barlesi, Maria Martinez-Garcia, et al.
Cell Reports. Medicine
|
February 28, 2024
Nilotinib in KIT-driven advanced melanoma: Results from the phase II single-arm NICAM trial
James Larkin, Richard Marais, Nuria Porta, et al.
Page
of 53